HAIC in Combination with Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors for Advanced HCC

Clinical trial NCT06632106 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06632106
Sponsor: First Hospital of China Medical University
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Hepatic Arterial Infusion Chemotherapy Tyrosine Kinase Inhibitor Immune Checkpoint Inhibitors Hepatocellular Carcinoma (HCC)

Start date: 2024-08-16
Primary completion: 2025-01-30
Enrollment: 97

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.